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Summary
IL-1b is produced from inactive pro-IL-1b by acti-
vation of caspase-1 brought about by a multi-
subunit protein platform called the inflammasome.
Many bacteria can trigger inflammasome activity
through flagellin activation of the host protein
NLRC4. However, strains of the common human
pathogen Pseudomonas aeruginosa lacking flagel-
lin can still activate the inflammasome. We set out
to identify what non-flagellin components could
produce this activation. Using mass spectroscopy,
we identified an inflammasome-activating factor
from P. aeruginosa as pilin, the major component
of the type IV bacterial pilus. Purified pilin intro-
duced into mouse macrophages by liposomal
delivery activated caspase-1 and led to secretion
of mature IL-1b, as did recombinant pilin purified
from Escherichia coli. This was dependent on
caspase-1 but not on the host inflammasome pro-
teins NLRC4, NLRP3 or ASC. Mutants of P. aerugi-
nosa strain PA103 lacking pilin did not activate the
inflammasome following infection of macrophages
with live bacteria. Type III secretion remained intact
in the absence of pili, showing this was not due to
a lack of effector delivery. Our observations show
pilin is a novel activator of the inflammasome in
addition to flagellin and the recently described
PrgJ protein family, the basal body rod component
of the type III apparatus.
Introduction
IL-1b is a key inflammatory cytokine important in host
defence that mediates a diverse range of effects, includ-
ing T-cell polarization, antibody production, fever and
endothelial and phagocyte activation (O’Neill, 2008;
Dinarello, 2009). IL-1b is an ancient molecule, appearing
early in vertebrate evolution, with clear homologues in
teleost fish indicating conservation over 450 million
years since fish and tetrapods split (Bird et al., 2002).
IL-1b is synthesized as an inactive pro form that requires
proteolytic processing to the mature active protein that
is released from cells (Auron et al., 1984). This process-
ing is carried out by caspase-1, itself produced as an
inactive precursor that also requires proteolytic pro-
cessing to become active (Thornberry et al., 1992). This
is a tightly controlled process performed by a multi-
subunit protein complex termed the inflammasome,
located in the cytoplasm (Yu and Finlay, 2008; Franchi
et al., 2009; Martinon et al., 2009). The inflammasome
brings together a sensor protein and the inactive
caspase-1 zymogen, usually with an adaptor protein. A
variety of diverse stimuli can activate the inflammasome,
leading to proteolytic processing of caspase-1, matura-
tion of pro-IL-1b to IL-1b and its release from the cell.
This is often accompanied by a form of cell death
termed pyroptosis (Bergsbaken et al., 2009). Under-
standing the triggers that lead to inflammasome activa-
tion following microbial infection is crucial in appreciating
how IL-1b innate host defence is controlled, how
microbes might evade such detection and how this
system might be manipulated to augment both innate
and acquired immune responses.cmi_1541 388..401
The sensor protein within the inflammasome typically
belongs to the nucleotide-binding domain leucine-rich
repeat containing (NLR) gene family (Ting et al., 2008; Ye
and Ting, 2008). Distinct inflammasomes are formed that
are differentiated by the NLR protein that they contain,
and that respond to distinct stimuli. NLRs form a large
protein family with over 20 members in humans and mice.
Two prototypic inflammasomes are those based on the
NLR protein NLRP3 [also known as NALP3 or cryopyrin
(Agostini et al., 2004; Mariathasan et al., 2006; Sutter-
wala et al., 2006)] and NLRC4 [also known as IPAF,
CARD12 or CLAN (Mariathasan et al., 2004)]. The
NLRP3 inflammasome is activated by a range of stimuli,
including ATP, uric acid crystals, alum and pore-forming
bacterial toxins (Martinon et al., 2009). In contrast, the
NLRC4 inflammasome is activated by intracellular micro-
bial products (Evans, 2009), the best characterized of
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which is the bacterial protein flagellin, the main compo-
nent of flagella (Franchi et al., 2006; Miao et al., 2006).
Both NLRP3 and NLRC4 inflammasomes usually contain
the adaptor protein ASC, which is also required for acti-
vation (Mariathasan et al., 2004).
Most Gram-negative bacteria that can activate the
NLRC4 inflammasome do so in a way that is completely
dependent on the bacterial type III secretion system
(TTSS). The TTSS is a mechanism whereby Gram-
negative bacteria can introduce a variety of virulence
factors directly into the host cell (Cornelis and Van Gijse-
gem, 2000). Structurally, the TTSS resembles a hypoder-
mic syringe: the ‘needle’ of the complex forms a conduit
between the bacterium and the host cell cytoplasm
through which a variety of toxins can be passed (Johnson
et al., 2005). Pseudomonas aeruginosa is an important
human pathogen that possesses a TTSS. It is the main
cause of hospital-acquired pneumonia and of lung
disease in patients with cystic fibrosis, as well as infec-
tions in patients with neutropenia and burns (Pier and
Ramphal, 2005). P. aeruginosa produces strong activation
of the NLRC4 inflammasome in a TTSS-dependent
fashion (Franchi et al., 2007; Sutterwala et al., 2007; Miao
et al., 2008); flagellin introduced into the host cell cyto-
plasm via the TTSS is suggested to be the means
whereby this organism activates the NLRC4 inflamma-
some. However, non-flagellated strains of P. aeruginosa
can activate the inflammasome, indicating that there must
be other mechanisms by which the NLRC4 inflamma-
some can be activated (Sutterwala et al., 2007).
Here, we set out to discover what other microbial factors
from P. aeruginosa could activate the inflammasome. We
have identified bacterial pilin, the main protein constituent
of bacterial type IV pili as a novel inflammasome activator
when introduced into macrophage cytoplasm. This is deliv-
ered in a process dependent on the bacterial TTSS, prob-
ably via the secretion apparatus itself. Type IV pili are found
in a variety of different bacteria with conservation of the
pilin molecule and are often important virulence determi-
nants (Craig et al., 2004), all features that are typical of
microbial determinants recognized by innate immune
receptors. While this work was ongoing, the PrgJ family
of proteins were identified as activators of the NLRC4
inflammasome (Miao et al., 2010). Pilin activation of the
inflammasome provides an additional innate immune
mechanism that can recognize pathogenic bacteria and
initiate a powerful host defence response.
Results
A pseudomonal protein distinct from flagellin activates
the inflammasome
The P. aeruginosa strain PA103DUDT has a competent
type III secretion system but does not translocate any
toxins (Vallis et al., 1999). This strain lacks flagellin (Liu,
1966) yet is still able to activate the inflammasome via the
host NLR protein, NLRC4 (Sutterwala et al., 2007). This is
dependent on the bacterial type III secretion system, but
not on any secreted toxin. In an effort to identify the factor
produced by PA103DUDT responsible for activating the
inflammasome, we purified material shed from the bacte-
rium after physical agitation, using a protocol designed to
isolate flagellin. Analysis of this material by SDS-PAGE
showed it to contain a single detectable protein band
of approximate mass 16 kDa (Fig. 1A). This was in con-
trast to protein isolated in the same fashion from the
flagellated strain PAO1, which has molecular mass of
approximately 53 kDa, as described for the b type flagellin
of this strain (Arora et al., 2000). We confirmed this by
immunoblotting this material with an antibody to flagellin,
which recognized a 53 kDa protein in the PAO1 strain but
did not react with material from PA103DUDT (Fig. 1B).
Flagellin-mediated swimming motility was also absent in
PA103DUDT but present in PAO1 (Fig. 1C).
We tested this 16 kDa protein containing fraction from
PA103DUDT for its ability to activate the inflammasome
within bone-marrow-derived murine macrophages
(BMDMs) in the presence of the liposomal transfection
reagent DOTAP to introduce the protein directly into the
macrophage cytoplasm. This combination resulted in
secretion of mature IL-1b from BMDMs (Fig. 1D), whereas
the protein alone or DOTAP alone produced little IL-1b.
Control transfections with ovalbumen also failed to
produce significant IL-1b (Fig. 1D). The levels achieved in
our transfections with the 16 kDa material were over
200 pg 106 cells-1 (Fig. 1D, right hand y-axis), which is
similar to the levels observed from transfected purified
flagellin (Miao et al., 2006 and C. S. Lindestam Arlehamn
and T. J. Evans, unpubl. obs.).
The 16 kDa protein from PA103DUDT that activates the
inflammasome is type IV pilin
The 16 kDa protein shown in Fig. 1A was isolated,
digested with trypsin and individual peptides separated by
liquid chromatography before sequencing using tandem
mass spectrometry and analysis with the programme
Mascot (Perkins et al., 1999) (Fig. S1). Nine unique pep-
tides were sequenced and matched to the 15.8 kDa pilin
protein from strain PA103 with a score of 830, correspond-
ing to a probability of match by chance alone of 10-83. This
protein accounted for 96% of the protein band analysed,
as determined by the exponentially modified protein abun-
dance index (Perkins et al., 1999).
To extend these observations, we re-purified material
from PA103DUDT using a protocol specific for isolation of
pilin, and tested its ability to activate the inflammasome at
different concentrations in combination with the transfec-
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tion reagent DOTAP (Fig. 2A and B). We found as before
that pilin with DOTAP stimulated the production of IL-1b,
whereas pilin or DOTAP alone had no or little effect; the
control protein ovalbumen plus DOTAP was also ineffec-
tive (Fig. 2A). In these experiments, cytotoxicity was
< 15% and all IL-1b levels are corrected for release of
unprocessed pro-IL-1b as described in Methods. Note
also that LPS (2 mg ml-1) is continuously present in
the experimental set-up, including when the DOTAP is
added to the cells. However, in contrast to other reports
(Kanneganti et al., 2007), we only found small amounts of
IL-1b produced under these conditions, which were
always significantly increased by the addition of pilin.
In a similar fashion, introduction of PA103DUDT pilin
into BMDMs produced activation of caspase-1, as evi-
denced by the appearance of the processed p10 subunit
of caspase-1 following transfection of the pilin protein
(Fig. 2B). Again, as a control, transfected ovalbumen was
without effect, as was equivalent volumes of material puri-
fied form bacteria lacking pilin. Thus, introduction of pilin
into the cytoplasm of BMDMs results in activation of the
inflammasome, with processing of caspase-1 and produc-
tion of mature IL-1b, but little cytotoxicity.
Next, we purified pilin from a different strain of P. aerugi-
nosa, PAO1. This strain is normally flagellated (Fig. 1B
and C). Using the same purification protocol as used for
PA103DUDT, we failed to isolate any pilin from the wild-
type PAO1 strain (Fig. 1A), despite this strain having
twitching motility, a phenotypic marker of functional type
IV pili [(Murray and Kazmierczak, 2008) and data not
shown]. However, when the flagellin gene fliC was
deleted, pilin could be readily purified from the mutant
(Fig. 2C). This suggests that in the presence of flagellin,
either the level of pilin expression is significantly down-
regulated or that it becomes much more tightly associated
with the bacterial cell and hence not amenable to bio-
chemical purification. PAO1 pilin transfected into BMDMs
activated the inflammasome leading to secretion of
mature IL-1b and processing of caspase-1 (Fig. 2D and
E). However, the absolute level of IL-1b released was less
than with the PA103 pilin as was the degree of caspase-1
cleavage, suggesting that pilin from PA103 is a more
potent activator of the inflammasome than that from
PAO1.
To provide additional evidence that pilin is an activator
of the inflammasome, we expressed PA103 pilin as a
fusion protein in Escherichia coli, removed the fusion
partner, and then purified the pilin away from other pro-
teins, as described in Methods and shown in Fig. S2.
Full-length pilin is very insoluble because of its hydropho-
bic N-terminus (Hazes et al., 2000). Thus, the expressed
recombinant protein was truncated to omit the first 30
amino acids. When this protein was introduced into
BMDMs using DOTAP, there was production of mature
Fig. 1. A 16 kDa protein fraction from P. aeruginosa PA103 can
activate the inflammasome.
A. SDS-PAGE analysis of material purified after agitation of
indicated bacterial suspension cultures and stained with colloidal
Coomassie Blue. 400 ng (lanes 1 and 3) or 200 ng (lanes 2 and 4)
protein loaded. Molecular weight markers (kDa) shown to the left.
Experiment repeated over five times.
B. Immunoblot of same protein material as in a using anti-flagellin
antibody. Experiment repeated with same results.
C. Phenotypic analysis of presence of flagella using swimming
motility plates for indicated bacteria. Bar shows 2 cm. Repeated
more than three times with same results.
D. IL-1b release following treatment of BMDMs as indicated. Values
are corrected for release of unprocessed IL-1b. Left-hand y-axis
shows absolute values obtained (pg ml-1); right-hand axis shows
amount (pg) produced per 106 cells. Columns are means of three
independent determinations and same results obtained on more
than three occasions; error bars are  SEM. The asterisk indicates
significantly different from DOTAP alone, 0.01 < P < 0.05, unpaired
t-test. 16 kDa is the protein fraction shown in a lane 1, OVA is
ovalbumen.
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IL-1b with little cytotoxicity (Fig. 3). DOTAP alone pro-
duced rather more IL-1b than seen in Fig. 2; this varied
with the batch of DOTAP and suggests additional mecha-
nisms of inflammasome activation.
Inflammasome components required to detect
transfected pilin
A number of proteins play a role in inflammasome activa-
tion following infection of BMDMs with P. aeruginosa.
NLRC4 is the key component identified as responsible for
activation of macrophages by flagellin. The adaptor
protein, ASC, also plays a role in this process. NLRP3 is
important in inflammasome activation in response to ATP
and a number of other diverse stimuli, but not in response
to infection with P. aeruginosa. In order to determine
which inflammasome components were required to
respond to transfected pilin, we isolated BMDMs from
mice with homozygous deletions in these genes, as well
as caspase-1, the enzyme responsible for IL-1b process-
ing. Using these cells, we then assayed their ability to
produce IL-1b following transfection of PA103 pilin with
DOTAP (Fig. 4). As before, wild-type BMDMs responded
to pilin only in the presence of the transfection reagent
DOTAP. Cells from animals with homozygous deletion
of NLRC4, NLRP3 and ASC responded to transfected
pilin as well as wild-type cells (Fig. 4). Indeed, cells from
the NLRP3-/- mice produced a just significantly higher
amount of IL-1b than the wild type. Cells from mice with
knockout of caspase-1 did not produce any response.
Thus, transfected pilin activates the inflammasome in a
fashion that is not dependent on NLRC4, NLRP3 or ASC
but does depend on caspase-1. This is in contrast to the
components required to respond to PA103 infection,
which is dependent on NLRC4 and ASC as well as
caspase-1. This is considered further in Discussion.
We also measured cytotoxicity in these experiments as
% LDH release. In the wild-type mice in this experiment,
we observed rather higher cytotoxicity of about 25% com-
pared with the experiments reported earlier with trans-
fected pilin (Fig. 4B). This variability seemed to correlate
with the batch of DOTAP being used. Cells from mice with
knockout of NLRC4 and ASC did show a significant reduc-
tion in cytotoxicity compared with wild-type cells, suggest-
ing these components contribute to cytotoxicity if not IL-1b
production (Fig. 4B).
Pilin activation of the inflammasome is protein and not
DNA dependent
Bacterial DNA is known to activate the inflammasome
following transfection and might contaminate the protein
samples used in these experiments, although transfected
DNA has a strict requirement for ASC to activate the
inflammasome, so this would seem unlikely. To be certain
this was not the case, we assayed for DNA in our samples
and found it was less than the limit of detectability
(< 5 ng). As a further control we subjected the pilin sample
to DNAse I digestion. This did not alter its ability to acti-
vate the inflammasome (Fig. 5A). Control digests of
plasmid DNA confirmed that the DNAse was active and
could abolish the inflammasome activating activity of
plasmid DNA (Fig. 5A). Additionally, pilin did not inhibit the
ability of DNAse I to digest DNA (Fig. S3).
As a further confirmation that the protein pilin was
responsible for inflammasome activation following trans-
fection, we digested it with pyrococcal protease S. This
significantly reduced its ability to activate the inflamma-
some to the levels seen with the DOTAP transfection
agent alone (Fig. 5B). This supports the conclusion that
the material purified from bacteria that activates the
inflammasome is protein.
Pilin mutants abolish inflammasome activation by PA103
Next, we tested strains of PA103 lacking the gene encod-
ing pilin (pilA) for their ability to activate the inflamma-
some. At a number of different multiplicities of infection
(MOI) the strain lacking pilin (PA103 DUDT pilA-) failed to
produce IL-1b secretion (Fig. 6A). IL-1b secretion by
PA103 DUDT pilA- was comparable with the PA103 DpcrV
mutant that does not elaborate a functional type III appa-
ratus (Fig. 6A). Caspase-1 processing by the pilA- mutant
was considerably reduced at all MOIs compared with the
wild-type strain (Fig. 6B) although not to the same extent
as the PA103 DpcrV mutant. Cytotoxicity as measured by
LDH release was not significantly different between
PA103 DUDT wild type and pilA- strain at all the MOIs
tested (Fig. 6C); the PA103 DpcrV strain had lower cyto-
toxic effects that did not significantly differ from the values
for uninfected cells (Fig. 6C). All three strains were able to
induce macrophage production of TNF-a, with no signifi-
cant difference between them (Fig. 6D). IL-6 production
after macrophage infection was higher for the pilA- strain
compared with the pcrV- mutant at all MOIs, while that
for the wild-type strain increased with increasing MOI
(Fig. 6E). Functional loss of pilin was confirmed in the
pilA- mutant by assaying for twitching motility (Fig. 6F), a
characteristic property of type IV pili (Mattick, 2002).
Taken together, these data show that inflammasome acti-
vation by PA103 DUDT is dependent on the presence of
type IV pili.
Lack of pilin does not impair type III toxin translocation
into macrophages
Type IV pili are known to act as adhesins for P. aeruginosa,
mediating attachment to epithelial cells (Hahn, 1997).
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Thus, one possible explanation for the loss of inflamma-
some activation observed in the PA103DUDTpilA- mutant
is that it fails to attach to macrophages and cannot mediate
type III secretion, hence behaving like the pcrV- mutant,
which cannot activate the inflammasome. To investigate
the ability of the pilA- mutant to translocate a type III
secreted effector, we assayed for the translocation of the
type III exported toxin ExoU, a potent phospholipase (Sato
et al., 2003). This toxin produces significant cytotoxicity
when translocated into host cells that can be abrogated by
inhibiting its phospholipase activity with MAFP (Sato et al.,
2003), but is completely inactive when extracellular as it
has an absolute requirement for an intracellular eukaryotic
cofactor now identified as superoxide dismutase (Sato
et al., 2006). Pseudomonal strains lacking the essential
TTSS component PcrV cannot translocate toxins into cells
but constitutively secrete exotoxins into the growth media
(Sawa et al., 1999). PcrV mutants of ExoU secreting
Pseudomonal strains are not cytotoxic, confirming that
ExoU cannot act extracellularly (Sawa et al., 1999). The
PA103DUDT strain gives little cytotoxicity following infec-
tion of BMDMs as noted before (Fig. 7). The wild-type
PA103 produces considerable cytotoxicity that is abolished
by treatment with the ExoU inhibitor MAFP (Fig. 7). This
reflects its ability to translocate ExoU into the macroph-
ages. The cytotoxic effect of PA103 lacking pilA (PA103
pilA-), but still encoding a functional ExoU protein, was not
significantly different from the wild-type strain. Importantly,
this cytotoxic action could be abolished by treatment with
the ExoU phospholipase inhibitor MAFP (Fig. 7). Thus,
lack of pili did not prevent P. aeruginosa translocating ExoU
into cells, showing that pili are not required for effective
type III translocation into macrophages.
Discussion
The data presented here have identified type IV pilin from
P. aeruginosa, the major structural protein of type IV pili,
as a novel activator of the inflammasome when intro-
duced into the cytoplasm via the bacterial TTSS. Both
natural and recombinant pilin activated the inflammasome
when transfected into cells (Figs 1–3) and the activity was
protease-sensitive but not destroyed by DNase (Fig. 5).
The PA103 strain lacking pilin was unable to activate the
inflammasome despite continued translocation of type III
exported toxins (Fig. 7). Taken together, these data dem-
Fig. 2. Dose–response curves of pilin activation of the inflammasome.
A. Secreted IL-1b from BMDMs (corrected for release of unprocessed IL-1b) in response to indicated amounts of pilin in the presence of
DOTAP (inverted filled triangles). Result with pilin alone at 500 ng shown as filled triangle. Values are means of three independent
determinations; error bars are  SEM. Repeated on two further occasions with similar results. Values for DOTAP alone, Ova and Ova plus
DOTAP are shown to the right. Differences between doses of pilin are statistically significant (One-way ANOVA, P < 0.0001), with a significant
increase with dose (P < 0.0001).
B. Immunoblot with anti p10 caspase-1 of cell extracts from BMDMs treated as shown. Arrows indicate the unprocessed caspase-1 (Casp 1)
and the p10 processed subunit (Casp 10 p10). These bands are absent in infected cells from caspase-1 knockout animals [(Lindestam
Arlehamn et al., 2010) and data not shown]. Representative of three separate experiments.
C. SDS-PAGE analysis of material purified after agitation of indicated bacterial suspension cultures and stained with colloidal Coomassie Blue.
Molecular weight markers (kDa) are shown to the left. Representative of three separate experiments.
D as A, but using pilin purified from PAO1:fliC-. Differences between doses of pilin are statistically significant (One-way ANOVA, P = 0.0001),
with a significant increase with dose (P = 0.004).
E. Immunoblot with anti p10 caspase-1 of cell extracts from BMDMs treated as shown. Arrows indicate the unprocessed caspase-1 (Casp 1)
and the p10 processed subunit (Casp 10 p10). Experiment repeated with similar results.
Fig. 3. Recombinant pilin activates the inflammasome. Purified
recombinant pilin (rPilin), ovalbumen or nothing was added to
BMDMs in the presence or absence of the transfection reagent
DOTAP as indicated. Cells were analysed for release of mature
IL-1b (A) or cytotoxicity (B) as shown. rPilin produced a significantly
higher amount of IL-1b compared with ovalbumen (**, two-sample
t-test, P < 0.01). Results are the means of triplicate determinations;
error bars are  1 SEM. The experiment was repeated on two
further occasions with the same result.
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Fig. 4. Pilin activation of the inflammasome is dependent on
caspase-1 but not NLRP3, NLRC4 or ASC. BMDMs from wild-type
(WT) mice or animals were transfected with DOTAP alone (open
bars), pilin alone (grey bars) or DOTAP + Pilin (black bars).
A shows secreted IL-1b corrected for release of immature
pro-IL-1b. Bars are means of triplicate independent determinations;
error bars are  SEM. Similar results were obtained on repeating
the experiment on two further occasions. There were significant
differences between the values of pilin + DOTAP between the
different animals (P < 0.0001 one-way ANOVA), with significant rise
in the NLRP3-/- mice (*P < 0.05 vs. WT animals, Bonferroni multiple
comparison test) and highly significant reduction in Casp 1-/- mice
(***P < 0.001 vs. WT animals, Bonferroni multiple comparison test).
B shows cytotoxicity after infection of the macrophages from the
various mice strains as measured by LDH release. Bars are means
of triplicate independent determinations; error bars are  SEM.
Differences between mice strains are significant (P = 0.005,
one-way ANOVA) with significant reductions as tested by
Bonferroni multiple comparison test in BMDMs from NLRC4-/- mice
(*P < 0.05), ASC-/- mice (P < 0.01) and Casp 1-/- mice (P < 0.001)
all compared with WT.
Fig. 5. Pilin stimulation of the inflammasome is not affected by
DNAse and is reduced by pyrococcal protease S.
A. BMDMs were treated as indicated with PA103 pilin (250 ng) or
plasmid DNA (pUCP20) and DOTAP and/or DNAse I as shown
prior to IL-1b measurement in supernatant. Bars are means of
three independent determinations; errors bars are  SEM. Effects
of DNAse I treatment were compared with control values by
unpaired t-test. For pilin no significant change was observed (n.s.
not significant); DNAse significantly reduced the IL-1b released
(**P < 0.001).
B. Pilin was left untreated or digested with pyrococcal protease S
before stimulation of BMDMs in the presence of DOTAP and
measurement of released IL-1b. Results are means of three
independent determinations; error bars are  SEM. Untreated
pilin + DOTAP produced significantly more IL-1b than DOTAP alone
(**P < 0.001, unpaired t-test); proteinase S-treated material was not
significantly different from control.
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onstrate that both biochemically and in an in vitro infection
model, translocation of pilin via the type III secretion
system of P. aeruginosa can activate the inflammasome.
This is the first demonstration of recognition of type IV
pilin by pattern recognition receptors of the innate immune
system.
In almost all species, type IV pili are important virulence
determinants (Craig et al., 2004). Structurally, they are
formed of thousands of copies of pilin that show sequence
similarities between different species. These are all
attributes that would engender a strong selection pres-
sure for a pilin-specific pattern recognition receptor as
described here. Two main type IV pilin subtypes are rec-
ognized: type IVa and IVb that differ in length, leader
sequence and N-terminal modification (Craig et al., 2004).
P. aeruginosa pilins belong to the type IVa group and have
primary amino acid sequence homology to other type IVa
pilins. There is, however, some variation between different
strains of P. aeruginosa, with PA103 pilin having 80%
identity with PAO1 pilin (GenBank Accession AAG07913)
but only 65% identity with pilin from the PAK strain
(GenBank Accession P02973). A diagram showing the
sequence similarities between pilin from the pseudomonal
strains PAO1 and PA103 is shown in Fig. S4. Additionally,
P. aeruginosa has five different phylogenetic types of pilA
alleles, with differences in post-translational modifications
and different associations with cystic fibrosis (Kus et al.,
2004). Such variability in pilin sequence can contribute to
evading both innate and acquired immune responses.
Sequence variations in flagellin between different bacte-
rial species have also been associated with loss of rec-
ognition by an innate pattern recognition receptor, TLR5
(Andersen-Nissen et al., 2005). The differences reported
here between the potency of PA103 and PA01 pilin in
Fig. 6. Loss of pilin reduces activation of the
inflammasome following infection of BMDMs
with P. aeruginosa strain PA103. BMDMs
were infected with PA103DUDT, PA103pcrV-
or PA103DUDT: pilA- at different MOIs or left
uninfected. Following infection, secreted IL-1b
(A), TNF-a (D) and IL-6 (E) were determined
as well as released LDH as a marker of
cytotoxicity (C). Each point is the mean of
three separate determinations; error bars are
 SEM. Differences between the IL-1b
produced by PA103DUDT and PA103DUDT:
pilA- strains were significant at all MOIs
(unpaired t-test, *P < 0.05, ***P < 0.001). B
shows cellular lysates of BMDMs infected as
shown and immunoblotted for the p10
activated caspase-1 fragment. Arrows to the
left indicate unprocessed caspase-1 (Casp 1)
and the p10 fragment (Casp1 p10). F shows
pilin-dependent twitching motility of the
PA103DUDT strain that is absent when the
pilA gene is deleted, PA103DUDT: pilA-. Bar is
2 cm. All experiments were repeated at least
once.
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activating the inflammasome may reflect such selection
pressure. Glycosylation of pilin may also differ between
strains and contribute to variability in inflammasome
response (Smedley et al., 2005).
Structural analysis of pilin shows a high degree of archi-
tectural similarity between pilin from different bacterial
species. All pilins possess an N-terminal hydrophobic
a-helix that mediates pilus assembly by packing into a
hydrophobic helical bundle in the core of the filament
(Craig et al., 2004). This region shows the greatest
degree of amino acid conservation between pilins from
different organisms. The main areas of the molecule that
are exposed in the complete fibre are the area between
the N-terminal a-helix and the b sheets of the globular
head domain, and the C-terminal D region that contains a
conserved disulphide bridge. Given that a recombinant
truncated pilin lacking the N-terminal hydrophobic domain
can activate the inflammasome (Fig. 3), this region of the
molecule does not appear to be required for inflamma-
some activation. The exposed D region of pseudomonal
pilin is proposed to mediate attachment to epithelia
through binding to the glycolipids asialo-GM1 and
asialo-GM2 (Craig et al., 2004). However, this has been
contradicted by other studies (Schroeder et al., 2001).
Delineation of the region of the pilin molecule required to
activate the inflammasome will require further work. The
retroviral expression system employed by Lightfield et al.
(Lightfield et al., 2008) is a powerful method to identify
which regions of a protein are required for cell death as a
marker of inflammasome activation. Although retroviral
expression of pilin within BMDMs produced far fewer
transduced cells, this activity was not dependent on the
inflammasome (data not shown). Pilin must possess toxic
activities that are independent of inflammasome activity
and thus preventing this assay being used to follow
inflammasome activation.
A number of groups initially reported that P. aeruginosa
could activate the NLRC4 inflammasome in a process
dependent on the TTSS (Franchi et al., 2007; Sutterwala
et al., 2007; Miao et al., 2008). Miao et al. (Miao et al.,
2008) ascribed this activation to the delivery of flagellin via
the TTSS, although their earlier work in Salmonella typh-
imurium noted that at higher MOIs there was a flagellin-
independent mechanism leading to activation of the
NLRCP3 inflammasome. Sutterwala et al. noted that P.
aeruginosa strains lacking flagellin could still activate the
inflammasome, which they felt most likely was due to a
‘pore-like’ effect produced by the TTSS apparatus rather
than a specific product delivered into the host cell cyto-
plasm. Miao et al. subsequently have discovered that
the TTSS PrgJ rod protein family can also activate the
inflammasome (Miao et al., 2010). The PscI protein of
P. aeruginosa is a member of this protein family and can
produce NLRC4 activation. Our work identifies another
pseudomonal protein, pilin, that can activate the inflam-
masome. What relative role do these different bacterial
proteins – flagellin, PscI and pilin – play in activating
the inflammasome in the course of an infection with
P. aeruginosa?
Although flagellin is widely expressed among patho-
genic bacteria, there are many examples where flagella
are not produced by bacteria that produce disease, P.
aeruginosa included (von Götz et al., 2004). Thus, the
ability of pilin to activate the inflammasome as described
here can play an additional role in host defence against a
range of bacteria. Further research will be required to
determine the extent to which pilins from different bacte-
rial species are able to induce inflammasome activation.
Equally, the relative role of the type III rod protein PscI in
activating the inflammasome compared with either flagel-
lin or pilin is not clear. How and under what conditions this
protein is translocated by the type III apparatus is not
known. Importantly, we do not feel that activation of the
inflammasome by flagellin, PrgJ and pilin is mutually
Fig. 7. Type III translocation of ExoU into BMDMs is not defective
in pilA- mutants. BMDMs were infected with the ExoU secreting
strains PA103 (wild type) and PA103: pilA- as well as the non-ExoU
translocating strain PA103 DUDT, all at MOI of 30. Graph shows the
cytotoxicity following infection with the indicated strains measured
as % release of LDH in the absence (open bars) or presence
(filled bars) of the ExoU inhibitor MAFP. Bars are means of three
independent determinations; error bars are  SEM. There was no
statistically significant difference between the PA103 and PA103:
pilA- strains in the cytotoxicity they produced. In the presence of
MAFP, both strains showed a statistically significant reduction in
cytotoxicity compared with absence of inhibitor (**P < 0.01,
unpaired t-test). The experiment was repeated on two further
occasions with the same results.
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exclusive, but rather that they can all play a role in differ-
ent bacterial strains and infection conditions. Further
work is required to establish the relative contributions of
these different pseudomonal proteins in activation of the
inflammasome.
Although when pilin is introduced via the TTSS of the
bacterium inflammasome activation is dependent on the
components NLRC4 and ASC, when transfected into cells
nether of these proteins was required, although the
activation was caspase-1-dependent. Inflammasome
activation by viral DNA also shows a differential require-
ment for inflammasome components depending on the
means whereby the DNA reaches the cell cytoplasm
(Muruve et al., 2008). Thus, adenovirus DNA introduced
by infection of macrophages by virus activates the inflam-
masome by a NLRP3- and ASC-dependent process.
However, when adenoviral DNA is introduced into cells
by liposomal-mediated transfection, the inflammasome
activation produced is not dependent on NLRP3, although
it does remain ASC-dependent (Muruve et al., 2008).
These data suggest that the sensors involved in detecting
cytoplasmic danger signals such as DNA or pilin are
compartmentalized, and that different inflammasome
components may be utilized in different cellular compart-
ments. As yet, no direct interaction has been detected
between a pathogen-associated molecule and an inflam-
masome component, suggesting that either additional
inflammasome components are involved, or that the acti-
vation is indirect. One possible means of indirect recog-
nition is a system that monitors perturbation of a host
protein by pathogen-derived molecules, as has been
found in a number of examples of plant resistance that
also uses NLR family proteins, the so-called ‘Guard
Hypothesis’ (Marathe and Dinesh-Kumar, 2003). Further
work will be required to identify the possible additional
inflammasome components that may be involved in
inflammasome activation by pilin. ASC-independent IL-1b
production is described in Legionella pneumophila infec-
tion (Case et al., 2009) as well as activation of the
NLRP1b inflammasome by muramyl dipeptide (Hsu et al.,
2008).
As with delivery of flagellin into the host cell, inflamma-
some activation by pseudomonal pilin is dependent on the
bacterial TTSS. Delivery of proteins via the TTSS is
usually very specific, with secreted toxins requiring a spe-
cific protein chaperone to enter the TTSS apparatus.
Because flagellin is exported into the flagellum via a
TTSS, delivery into a host cell was proposed to occur
through flexibility in the TTSS secretion signal (Miao et al.,
2006). Type IV pili biogenesis requires the passage of pilin
across bacterial membranes, a process involving over a
dozen proteins (Proft and Baker, 2009). Passage of pilin
across the outer membrane of Gram-negative bacteria
requires a transmembrane protein of the secretin family
(Bitter, 2003). Secretin family members also form the
outer membrane part of the TTSS. We do not know how
pilin reaches the host cell cytoplasm in a TTSS-dependent
fashion, but one possible explanation is through recogni-
tion of pilin by secretin family members, resulting in ‘acci-
dental’ passage of pilin through the TTSS. It has also
been proposed that the TTSS may act as a somewhat
leaky ‘pore’, enabling other bacterially derived macromol-
ecules access to host cell cytoplasm in a non-specific
fashion (Neyt and Cornelis, 1999). We find no evidence
that the TTSS of P. aeruginosa forms a leaky pore (Lind-
estam Arlehamn et al., 2010). As with detection of flagel-
lin, host recognition of cytoplasmic pilin is a sensitive
indicator of bacterial invasion, a danger signal whose
recognition by the innate immune system would provide
considerable evolutionary selection advantage. Pilin may
also be delivered into the host cell cytoplasm by escape
from bacteria within the phagocytic vacuole. Whatever the
mechanism, inflammasome activation and the production
of IL-1b results in an appropriate immune response to
invading bacteria, to augment the responses triggered by
other bacterial components.
Experimental procedures
Bone-marrow-derived macrophages and mice
All animal studies were carried out under the relevant national
guidelines. C57Bl/6 mice femurs and tibias were used a source of
bone-marrow-derived macrophages. Bone-marrow mononuclear
phagocytic precursor cells were seeded into untreated 9 cm Petri
dishes (Sterilin) at a concentration of 3 ¥ 106 cells plate-1. Com-
plete media were further supplemented with M-CSF from super-
natant of L929 cells or as purified recombinant protein
(10 ng ml-1, Peprotech). Cells were cultured for 6–7 days until
mature, then scraped off and seeded into tissue culture dishes
before experiments.
Where indicated, BMDMs were derived from mice with lack of
caspase-1, NLRP3, NLRC4, and ASC, on a C57Bl/6 background
as previously described (Mariathasan et al., 2004; Martinon
et al., 2006).
Bacterial strains and growth
PA103DUDT and PA103pcrV- were kind gifts from Dara Frank,
Medical College of Wisconsin. PA103pilA- and PAO1 were a kind
gift from Barbara Kazmierczak, Yale University School of Medi-
cine (Murray and Kazmierczak, 2008). PA103DUDTpilA- was
constructed using standard methods from the strain PA103pilA-
(Choi et al., 2006).
Bacteria were grown routinely in Luria–Bertani (LB) media
(Invitrogen) containing the appropriate antibiotics depending on
bacterial strain. An overnight culture was diluted 1 in 30 in LB
and allowed to grow for another 90 min or until OD600 was
between 0.4 and 0.6. The bacteria were then centrifuged at
3000 g for 10 min at 4°C, the pellet was washed twice in sterile
PBS and then resuspended in the same media as the cells being
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infected to a concentration of approximately 1 ¥ 106 cfu ml-1, by
using a volume of (OD600/0.4) ¥ 1.8 ml. Cells were then infected
at the indicated MOI and time. When using mutants deficient in
flagellin and/or pilin, bacteria were spun onto cells for 5 min at
1500 g; however, we did not find this made any significant dif-
ference to the amount of IL-1b released. In some experiments
Methyl Arachidonyl Fluorophosphonate (MAFP; Calbiochem)
was added at a final concentration of 100 mM 60 min before
infection.
Lactate dehydrogenase (LDH) assay
Lactate dehydrogenase release determinations were performed
using the CytoTox 96 cytotoxicity assay kit (Promega). As a
positive control for total cell-associated LDH, cells were lysed
with 1% Triton X-100 at 37°C for 20 min. The % cell death was
determined according to % cytotoxicity = (experimental LDH
release/maximum LDH release) ¥ 100.
Western blotting
Following infection or stimulation as indicated, supernatants
were kept for ELISA and LDH assays. The cells were washed in
PBS and lysed in lysis buffer [50 mM Tris-HCl (pH 7.4)], 150 mM
NaCl, 5 mM EDTA, 1% (v/v) Triton X-100 supplemented with a
EDTA-free protease inhibitor cocktail (Complete Mini EDTA-free;
Roche). After lysis for 15 min at RT cells were scraped off and
stored at -70°C before Western blot analysis. For IL-1b analy-
sis, blots were incubated with a rabbit polyclonal antibody to the
p10 fragment of activated murine caspase-1 (Santa Cruz Bio-
technology). Anti-flagellin antibody was a mouse monoclonal
(Biolegend).
ELISA for IL-1b
ELISA for IL-1b was performed according to manufacturer’s
instructions (BD Biosciences). The release of pro-IL-1b from
dead cells was controlled for by analysing 0.9% Triton X-100
treated unstimulated macrophages, to release total pro-IL1b from
within the cells. This can be detected by the ELISA, although the
assay is more sensitive for the mature form. As described by
Miao et al. (Miao et al., 2006), values from experimental wells
were then corrected for the amount of pro-IL-1b released from the
dead cells according to the formula: Mature IL-1b = total IL-1b
signal - (pro-IL-1b lysis value ¥ percent release of LDH). Each
sample was assayed in duplicate. Results shown are the means
of three separate experiments.
Protein transfection
BMDM were seeded 2.5 ¥ 105 cells per well into 24-well plates
(Corning) in complete media with 2 mg ml-1 LPS. After 3 h at 37°C
in a humidified incubator cells were washed and media was
replaced with 300 ml RPMI without Phenol Red (Invitrogen)
supplemented with 2 mM L-glutamine and 2 mg ml-1 LPS. Pro-
teins (at the indicated final concentrations) were diluted in media
to a final volume of 50 ml and 2 mg N-[1-(2,3-Dioleoyloxy)propyl]-
N,N,N-trimethyl-ammonium methylsulfate (DOTAP) liposomal
transfection reagent (Roche) was added to appropriate tubes.
After 15 min incubation at RT the transfection mixture was added
to the cells and plates swirled to allow for even distribution. Plates
were incubated at 37°C for 3.5 h or as indicated. Following this
incubation cell lysates were prepared as described and superna-
tants were kept and analysed for LDH release and IL-1b secre-
tion. Levels of IL-1b did show some variation between different
batches of DOTAP, but in all cases simultaneous controls of
protein alone and DOTAP alone were performed to allow com-
parison with the value for protein plus DOTAP. Note that LPS is
continually present in our experimental set-up but this produced
little IL-1b in combination with DOTAP and levels with pilin were
always significantly higher as indicated.
Pilin purification
The pilin purification method used was based on a method
described by Smedley et al. (Smedley et al., 2005). Bacterial
strains were grown in Trypticase Soy Broth (TSB) with very gently
agitation (60 r.p.m.) at 37°C over night. The over night culture
was pelleted at 8000 r.p.m. for 13 min at 4°C in a Beckman
Coulter Avanti J-26 XP centrifuge. The pellet was resuspended in
25 ml PBS and vortexed hard, which was followed by vigorous
stirring using a magnetic stirrer for 30 min at RT with intermediate
vortexing. The bacterial suspension was then centrifuged at
16 000 r.p.m. in a Beckman Coulter Avanti J-26 XP centrifuge at
4°C for 30 min. The supernatant was kept and the NaCl concen-
tration was increased to 0.5 M and polyethylene glycol PEG 3000
was added to a final concentration of 3% v/v. The solution was
kept at 4°C for at least 18 h, following which precipitated proteins
were collected by centrifugation at 11 000 g at 4°C for 20 min.
The proteins were dissolved in 1 ml water and analysed using
SDS PAGE. For protein visualization, gels were stained with
colloidal Coomassie Blue (Instant Blue, Expedeon), which is able
to detect 5 ng of protein per lane. Protein concentrations were
determined using a modified Bradford assay (Bio-Rad) with BSA
as a standard.
Recombinant pilin production
An N-terminal truncated version of PA103 pilin was amplified by
PCR using the primers gatggatccgcttcggaaggcgcttcggc (forward)
and tcgaagcttggaatcgaacccccgacc (reverse) and cloned
between the BamH1 and HindIII sites (underlined) of pET41a
(Novagen, Merck Biosciences), which results in the pilin being
expressed from amino acid 31 of the mature protein in frame with
GST containing a His tag. The fusion protein was induced in
Rosetta E. coli (Novagen, Merck Biosciences) according to the
manufacturer’s instructions. The fusion protein was purified from
cleared bacterial lysates using nickel-NTA agarose (Invitrogen)
according to the manufacturer’s instructions. The GST tag was
cleaved from the fusion protein using high activity recombinant
enterokinase (Novagen, Merck Biosciences) and His tag bearing
impurities removed by Ni-NTA agarose as before. The purity of
the final protein was checked by SDS polyacrylamide gel elec-
trophoresis (Fig. S2).
DNAse and protease digestion
0.5 units of Pyrococcal protease S (Sigma) was added to
samples and incubated at 60°C for 60 min. DNAse1 (Qiagen; 0.5
Kunitz units) was added to samples and incubation performed at
37°C for 30 min.
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Twitch and swimming assays
Type IV pilus-mediated twitching motility assays were performed
as described (Semmler et al., 1999). Colonies from an agar plate
were picked up with a p200 pipette tip and stabbed through the
agar of a twitch agar plate. Plates were left at 30°C for 2 days and
then analysed for the twitch zones between the bottom of the
agar and the Petri dish. This was best visualized by careful
removal of the agar and viewing with an oblique light source.
Flagellin-mediated motility (‘swimming’) was determined as
described.
Statistical tests
Comparisons between two groups were made using the unpaired
t-test. For more than two groups, one-way ANOVA was used, with
post tests for trend or correction (Bonferroni) for multiple com-
parisons. Results were considered statistically significant if
P < 0.05.
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Fig. S1. Peptides identified from mass spectroscopy of tryptic
digest of 16 kDa protein matched to pilin using the programme
MASCOT. Mr (expt) is experimental mass, Mr (calc) is calculated
mass.
Fig. S2. Purification of recombinant truncated pilin. SDS poly-
acrylamide gel showing protein fractions of the purified fusion
protein (Fusion), the fusion protein after enterokinase digestion
(Fusion + EK), and the final purified pilin after contaminant
removal (Purified rPilin). Molecular weight markers are in lane M
with values in kDa shown to the left.
Fig. S3. Addition of pilin does not inhibit DNAse I. Plasmid DNA
was present in all samples and then digested with DNAse I as
indicated in the presence or absence of pilin (250 ng). DNA was
analysed by agarose gel electrophoresis and the presence of
plasmid DNA was detected by ethidium bromide staining. Size
markers (kb) are shown to the left.
Fig. S4. Diagram showing the sequence conservation between
pilin from the pseudomonal strains PAO1 and PA103. The upper
section shows the regions of identity between the two proteins as
shaded gray; differences in sequence are left white. Numbering
of the amino acids is shown above the blocks; 1 is the first amino
acid of the mature protein i.e. after cleavage of the signal
sequence. The lower section shows the main architectural fea-
tures of the pilin molecule. The hydrophobic segment of the a1
helical segment is shaded dark gray. The a/b loop is shaded
green and the D region shaded magenta, flanked by the two
conserved cysteine residues, shaded yellow.
Please note: Wiley-Blackwell are not responsible for the content
or functionality of any supporting materials supplied by the
authors. Any queries (other than missing material) should be
directed to the corresponding author for the article.
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